The Therapeutic Potential of Probiotics in Restoring Skin Microbiome Balance and Managing Dermatological Disorders

The skin microbiome is a diverse ecosystem essential that is for maintaining barrier integrity and regulating immune responses. Disruptions to this ecosystem (dysbiosis) are associated with a range of dermatological disorders (including acne, atopic dermatitis, and psoriasis). Probiotic skincare uses live, beneficial microorganisms or their derivatives to restore microbial balance, reduce inflammation, and strengthen the skin’s barrier. Mechanistically, probiotics produce antimicrobial substances (e.g., lactic acid, bacteriocins, and H2O2) that inhibit pathogens, lower skin pH, stimulate antimicrobial peptide production, and modulate immunity. Studies have shown effectiveness in key conditions. For example, probiotic strains (e.g., Streptococcus salivarius) can inhibit Cutibacterium acnes in acne treatment. Additionally, topical preparations derived from Vitreoscilla filiformis have been shown to reduce S. aureus colonization and improve clinical outcomes in atopic dermatitis. In psoriasis, oral probiotics have been shown to reduce disease severity and inflammation markers. Moreover, probiotic promote wound healing through anti-pathogenic and antibiofilm activities and protect against ultraviolet (UV)-induced damage by boosting antioxidant defenses. Emerging trends include the use of postbiotics (inactive probiotic components) and research into the gut–skin axis. Ongoing research is focused on identifying new probiotic strains, optimizing formulations, and developing targeted delivery methods to improve the use of probiotics in skincare applications. Meanwhile, growing consumer interest and market investment are accelerating translation into cosmetic and therapeutic products. Collectively, current evidence underscores the significant potential of probiotic-based strategies as adjunctive or novel approaches for the management of dermatological disorders.